查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1859042

治療性血液分離術市場報告：至2031年的趨勢、預測和競爭分析

Therapeutic Apheresis Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球治療性血液分離術市場前景廣闊，在醫院和診所市場蘊藏著巨大機會。預計2025年至2031年，全球治療性血液分離術市場將以6.7%的年複合成長率成長。推動該市場發展的關鍵因素包括自體免疫血液疾病盛行率的上升、對先進血液分離術的需求不斷成長以及人們對血漿療法益處的認知不斷提高。

  • Lucintel預測，在預測期內，治療性血漿置換將迎來高速成長。
  • 以使用量計算，醫院預計將出現更高的成長。
  • 從區域來看，預計亞太地區在預測期內將達到最高成長。

治療性血液分離術市場的新趨勢

在技術進步和對各種疾病狀況認知加深的推動下，治療性血液分離術市場正經歷顯著的變革。這些新興趨勢提升血液分離術的精準性、可近性和適用性，為越來越多的疾病提供更具針對性和更有效的治療方案。

  • 選擇性血液分離技術：目前的主要發展趨勢是開發高選擇性血液分離技術，該技術能夠特異性清除血液中的致病物質（例如自體抗體、冷球蛋白、低密度脂蛋白膽固醇），同時保留有益成分。這種精準性提高了療效，減少了副作用，拓寬了治療應用範圍，並最終改善了患者的治療效果。
  • 攜帶式分散式醫療：攜帶式血液分離機的普及使得門診和居家治療成為可能。這一趨勢的驅動力在於，人們對以患者為中心的醫療模式的需求日益成長，這有助於減輕醫院負擔、提高患者依從性，並改善需要頻繁治療的慢性疾病患者的生活品質。
  • 與細胞和基因療法的整合：治療性血液分離術與蓬勃發展的細胞和基因治療領域日益緊密地聯繫在一起，在收集特定細胞群（例如，CAR-T 療法的T 細胞、移植的幹細胞）和處理細胞激素釋放症候群等併發症發揮關鍵作用，鞏固了其在先進個性化醫療中的地位。
  • 自動化和智慧型設備：將自動化和人工智慧（AI）整合到血液分離系統中是關鍵趨勢。自動化系統簡化了複雜的操作流程，減少了人為錯誤，並提高了效率。人工智慧演算法最佳化了分離過程，確保了即時監測，並實現了個人化的治療調整，提高了患者的安全性和治療效果。
  • 治療應用範圍擴大：治療性血液分離術的應用範圍已從傳統的血液學和神經病學領域擴展到膿毒症治療、器官移植（去除供體特異性抗體）、某些腫瘤治療等新領域。適應症的多樣化顯著擴大了市場潛力，並推動了對先進系統的需求。

這些新興趨勢顯著地重塑治療性血液分離市場，使治療更加精準、便捷，並與尖端醫療相結合，實現個人化醫療，提高患者的便利性，並擴大血液分離可有效治療的疾病範圍，進而推動市場顯著成長。

治療性血液分離市場的最新趨勢

近年來，受疾病種類不斷增多和技術持續創新的推動，治療性血液分離術市場發生了顯著變化。這些進步帶來了更有效率、更精準、更便利的治療方案，顯著改善了多種疾病患者的治療效果。

  • 先進設備平台：推出新一代血液分離系統，該系統具備自動化、使用者友善介面和更高安全性。例如，Baxter International的PrisMax系統為多種器官支持療法（包括血液分離）提供了一個多功能平台，可簡化流程並提高重症加護環境的效率。
  • 標靶吸附技術：開發專門設計的吸附柱和過濾器，用於高度選擇性地去除特定病原體，能夠精確去除自體免疫疾病中的自身抗體和遺傳性高膽固醇症中的低密度脂蛋白膽固醇，進而實現更有針對性和更有效的治療。
  • 關注鐮狀細胞疾病：加大對治療性血液分離術（尤其是紅血球置換術）的關注和投入，以治療鐮狀細胞疾病。隨著Terumo Blood and Cell Technologies在各地實施目的是改善鐮狀細胞疾病患者護理的項目，血液分離術作為該疾病的重要治療方法正日益受到認可。
  • 與細胞和基因治療工作流程的整合：血球分離設備製造商與細胞和基因治療開發商之間的合作日益密切，目的是最佳化細胞採集流程。這確保了特定細胞類型的高效、高品質採集 - 這是個人化細胞療法生產的關鍵步驟 - 並推動了這些領域交叉領域的創新。
  • 分散式門診病人治療方案：開發可在傳統醫院環境之外（例如門診診所或家中）進行治療的血液分離術方案。這一趨勢滿足了患者對舒適性和便利性的日益成長的需求，減輕了醫院的負擔，並提高了需要頻繁治療的慢性病患者的就醫便利性。

這些近期趨勢共同影響著治療性血液分離術市場，提高了治療的準確性和效率，擴大了其對更廣泛疾病的適用範圍，並改善了患者的就醫便利性，進而推動了創新和應用，最終改善了患者的治療效果，並實現了市場的持續成長。

目錄

第1章 執行摘要

第2章 市場概覽

  • 背景和分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球治療性血液分離市場（依類型）

  • 概述
  • 吸引力分析：依類型
  • 治療性血漿置換：趨勢與預測（2019-2031）
  • 紅血球交換：趨勢與預測（2019-2031）

第5章 全球治療性血液分離市場（依應用領域）

  • 概述
  • 吸引力分析：依應用
  • 醫院：趨勢與預測（2019-2031）
  • 診所：趨勢與預測（2019-2031年）
  • 其他：趨勢與預測（2019-2031年）

第6章 區域分析

  • 概述
  • 全球治療性血液分離術市場（依地區）

第7章 北美治療性血液分離市場

  • 概述
  • 北美治療性血液分離市場（依類型）
  • 北美治療性血液分離市場（依應用）
  • 美國治療性血液分離術市場
  • 墨西哥治療性血液分離市場
  • 加拿大治療性血液分離市場

第8章 歐洲治療性血液分離市場

  • 概述
  • 歐洲治療性血液分離市場（依類型）
  • 歐洲治療性血液分離市場（依應用）
  • 德國治療性血液分離市場
  • 法國治療性血液分離市場
  • 西班牙治療性血液分離術市場
  • 義大利治療性血液分離市場
  • 英國治療性血液分離市場

第9章 亞太地區治療性血液分離市場

  • 概述
  • 亞太地區治療性血液分離市場（依類型）
  • 亞太地區治療性血液分離市場（依應用）
  • 日本治療性血液分離術市場
  • 印度治療性血液分離術市場
  • 中國治療性血液分離市場
  • 韓國治療性血液分離術市場
  • 印尼治療性血液分離市場

第10章 其他地區（ROW）治療性血液分離市場

  • 概述
  • ROW 治療性血液分離市場（依類型）
  • ROW 治療性血液分離市場（依應用）
  • 中東治療性血液分離市場
  • 南美洲治療性血液分離市場
  • 非洲治療性血液分離市場

第11章 競爭分析

  • 產品系列分析
  • 運作整合
  • 波特五力分析
    • 競爭敵對
    • 買方議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市場佔有率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 成長機會：依類型
    • 成長機會：依應用
  • 全球治療性血液分離市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 企業合併、協議、合作關係和合資企業

第13章 價值鏈中主要企業的概況

  • 競爭分析
  • Miltenyi Biotec
  • Fresenius
  • Terumo
  • Baxter
  • Medica Group

第14章 附錄

  • 圖表清單
  • 表格列表
  • 分析方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於 Lucintel
  • 詢問

The future of the global therapeutic apheresis market looks promising with opportunities in the hospital and clinic markets. The global therapeutic apheresis market is expected to grow with a CAGR of 6.7% from 2025 to 2031. The major drivers for this market are the increasing prevalence of autoimmune blood disorders, the rising demand for advanced apheresis procedures, and the growing awareness of plasma therapy benefits.

  • Lucintel forecasts that, within the type category, therapeutic plasma exchange is expected to witness higher growth over the forecast period.
  • Within the application category, hospital is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Therapeutic Apheresis Market

The therapeutic apheresis market is undergoing significant evolution, driven by technological advancements and a deeper understanding of various disease pathologies. These emerging trends are enhancing the precision, accessibility, and applicability of apheresis, leading to more targeted and effective treatments for a growing range of medical conditions.

  • Selective Apheresis Techniques: A key trend is the development of highly selective apheresis techniques that can specifically remove pathogenic substances (e.g., autoantibodies, cryoglobulins, LDL cholesterol) from the blood, while preserving beneficial components. This precision enhances efficacy, reduces side effects, and broadens therapeutic applications, leading to improved patient outcomes.
  • Portable and Decentralized Care: There's a growing shift towards portable apheresis devices and enabling treatments in outpatient settings or even at home. This trend is driven by the increasing demand for patient-centric care models, reducing the burden on hospitals, improving patient compliance, and enhancing the quality of life for chronic care patients requiring frequent treatments.
  • Integration with Cell and Gene Therapies: Therapeutic apheresis is becoming increasingly intertwined with the burgeoning field of cell and gene therapies. It plays a crucial role in collecting specific cell populations (e.g., T-cells for CAR-T therapy, stem cells for transplantation) and in managing complications like cytokine release syndrome, cementing its role in advanced personalized medicine.
  • Automation and Smart Devices: The integration of automation and artificial intelligence (AI) into apheresis systems is a significant trend. Automated systems simplify complex procedures, reduce human error, and enhance efficiency. AI algorithms can optimize separation processes, ensure real-time monitoring, and enable personalized treatment adjustments, improving patient safety and outcomes.
  • Expanded Therapeutic Applications: Beyond traditional uses in hematology and neurology, therapeutic apheresis is finding expanded applications in new areas, including sepsis management, organ transplantation (removing donor-specific antibodies), and certain oncology treatments. This diversification of indications is significantly broadening the market potential and driving demand for advanced systems.

These emerging trends are profoundly reshaping the therapeutic apheresis market by making treatments more precise, accessible, and integrated with cutting-edge medical advancements. They are enabling personalized care, improving patient convenience, and expanding the range of conditions effectively treatable with apheresis, thereby driving significant market growth.

Recent Developments in the Therapeutic Apheresis Market

The therapeutic apheresis market has witnessed a surge of transformative developments recently, fueled by increasing disease prevalence and continuous technological innovation. These advancements are leading to more efficient, precise, and accessible treatments, significantly improving patient outcomes for a wide array of conditions.

  • Advanced Device Platforms: Introduction of next-generation apheresis systems with enhanced automation, user-friendly interfaces, and improved safety features. For example, Baxter International's PrisMax system offers a versatile platform for various organ support therapies, including apheresis, streamlining procedures and increasing efficiency in critical care settings.
  • Targeted Adsorption Technologies: Development of specialized adsorption columns and filters designed for highly selective removal of specific pathogenic substances. Innovations like specific immunoadsorbents enable precise elimination of autoantibodies in autoimmune diseases or LDL cholesterol in familial hypercholesterolemia, leading to more targeted and effective treatments.
  • Focus on Sickle Cell Disease: Increased emphasis and investment in therapeutic apheresis, particularly red blood cell exchange, for the management of sickle cell disease. Initiatives like Terumo Blood and Cell Technologies' programs to enhance care for sickle cell patients in various regions highlight a growing recognition of apheresis as a critical therapy for this condition.
  • Integration with Cell and Gene Therapy Workflows: Growing collaboration between apheresis device manufacturers and cell/gene therapy developers to optimize cell collection processes. This ensures efficient and high-quality collection of specific cell types, a crucial step in the manufacturing of personalized cellular therapies, driving innovation at the intersection of fields.
  • Decentralized and Outpatient Care Solutions: Development of apheresis solutions that facilitate treatment outside traditional hospital settings, such as in outpatient clinics or even at home. This trend addresses the growing demand for patient comfort and convenience, reducing hospital burden and improving accessibility for chronic patients requiring frequent sessions.

These recent developments are collectively impacting the therapeutic apheresis market by enhancing the precision and efficiency of treatments, expanding their applicability to a broader range of diseases, and improving patient access and convenience. They are driving innovation and adoption, ultimately leading to better patient outcomes and sustained market growth.

Strategic Growth Opportunities in the Therapeutic Apheresis Market

The therapeutic apheresis market offers substantial strategic growth opportunities across key applications, driven by the increasing incidence of chronic and autoimmune diseases and the growing demand for targeted therapies. Capitalizing on these opportunities requires focused innovation, market penetration strategies, and addressing specific clinical needs.

  • Neurological Disorders Treatment: The rising prevalence of neurological autoimmune diseases like Guillain-Barre syndrome, myasthenia gravis, and multiple sclerosis presents a significant growth opportunity. Developing and promoting apheresis solutions (especially Therapeutic Plasma Exchange) tailored for these conditions, with a focus on rapid intervention and improved outcomes, will be crucial.
  • Autoimmune Disease Management: The broad spectrum of autoimmune diseases (e.g., lupus, rheumatoid arthritis, vasculitis) where conventional treatments are insufficient or have severe side effects offers a vast market. Strategic growth lies in developing specialized apheresis techniques and devices that can effectively remove specific autoantibodies and immune complexes, providing a vital therapeutic option.
  • Oncology Support and Cell Therapy: The growing field of oncology, particularly with the advent of CAR-T cell therapies and other cell-based treatments, creates substantial opportunities. Apheresis plays a critical role in collecting effector cells for these therapies and managing their side effects, making it an indispensable component of modern cancer treatment protocols.
  • Renal Disease Management: The increasing global burden of chronic kidney disease and end-stage renal disease drives demand for apheresis in managing complications like hypercholesterolemia and certain forms of glomerulonephritis. Innovations in LDL apheresis and other specific filtration techniques for kidney patients represent a key growth area.
  • Transplant Medicine and Organ Rejection: Apheresis is crucial in solid organ transplantation to remove donor-specific antibodies (DSAs) that can lead to rejection, both pre- and post-transplant. Strategic growth involves enhancing apheresis technologies for effective DSA removal, improving graft survival, and expanding its use in challenging transplant scenarios.

These strategic growth opportunities are poised to profoundly impact the therapeutic apheresis market by driving specialized product development, expanding market penetration into high-value medical segments, and solidifying apheresis's role as a cornerstone therapy in various chronic and critical conditions.

Therapeutic Apheresis Market Driver and Challenges

The therapeutic apheresis market is characterized by a dynamic interplay of various technological, economic, and regulatory factors. Major drivers include the increasing prevalence of chronic and autoimmune diseases, advancements in apheresis technologies, and the growing demand for plasma-derived therapies. However, the market also faces significant challenges such as the high cost of procedures, the lack of skilled professionals, and stringent regulatory complexities.

The factors responsible for driving the therapeutic apheresis market include:

1. Rising Incidence of Chronic and Autoimmune Diseases: The escalating global prevalence of conditions like multiple sclerosis, lupus, Guillain-Barre syndrome, and various hematological disorders significantly drives the demand for therapeutic apheresis. These diseases often require apheresis as a primary or adjunctive treatment, expanding its clinical utility.

2. Technological Advancements in Apheresis Devices: Continuous innovation in apheresis equipment, including automated systems, enhanced membrane filtration techniques, and more selective adsorption columns. These advancements improve procedure efficiency, precision, and patient safety, making apheresis a more viable and attractive treatment option.

3. Growing Demand for Plasma-Derived Therapies: The increasing need for plasma-derived medicinal products (PDMPs) such as immunoglobulins, albumin, and clotting factors, largely collected through plasmapheresis. This consistent demand from the biopharmaceutical industry provides a strong underlying driver for the apheresis market.

4. Expansion of Therapeutic Applications: Beyond traditional uses, therapeutic apheresis is finding new applications in areas like sepsis management, organ transplantation (e.g., desensitization), and various oncological treatments. This diversification of indications broadens the market potential and drives further adoption.

5. Favorable Reimbursement Policies: In developed economies, favorable reimbursement policies and government support for apheresis procedures encourage healthcare providers to offer these therapies. This financial backing reduces the burden on patients and healthcare systems, thereby facilitating wider adoption.

Challenges in the therapeutic apheresis market are:

1. High Cost of Procedures and Equipment: The significant capital expenditure required for purchasing apheresis devices and the recurring costs of disposable kits and skilled personnel. This high cost can limit the accessibility of therapeutic apheresis, particularly in developing regions or for patients without adequate insurance coverage.

2. Lack of Skilled Professionals: The specialized nature of therapeutic apheresis procedures necessitates highly trained and skilled healthcare professionals (e.g., apheresis nurses, medical technologists). A shortage of such qualified personnel in many regions poses a significant challenge, impacting the capacity and quality of apheresis services.

3. Regulatory Complexities: Stringent and evolving regulatory frameworks for apheresis devices, consumables, and therapeutic applications. Navigating these complex approval processes can be time-consuming and costly for manufacturers, potentially delaying market entry for innovative products and limiting their widespread availability.

The therapeutic apheresis market is on a trajectory of robust growth, propelled by the rising global burden of chronic diseases and continuous technological innovations that enhance treatment efficacy. However, addressing the critical challenges of high costs, the shortage of skilled professionals, and regulatory complexities will be crucial to ensure broader patient access and unlock the full potential of these life-saving therapies.

List of Therapeutic Apheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies therapeutic apheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the therapeutic apheresis companies profiled in this report include-

  • Miltenyi Biotec
  • Fresenius
  • Terumo
  • Baxter
  • Medica Group

Therapeutic Apheresis Market by Segment

The study includes a forecast for the global therapeutic apheresis market by type, application, and region.

Therapeutic Apheresis Market by Type [Value from 2019 to 2031]:

  • Therapeutic Plasma Exchange
  • Red Blood Cell Exchange

Therapeutic Apheresis Market by Application [Value from 2019 to 2031]:

  • Hospital
  • Clinic
  • Others

Therapeutic Apheresis Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Therapeutic Apheresis Market

Recent developments in the therapeutic apheresis market are transforming the treatment of numerous critical illnesses, from autoimmune disorders to neurological conditions. Driven by advancements in device technology, increasing prevalence of chronic diseases, and a shift towards personalized medicine, apheresis is becoming a cornerstone of modern treatment regimens, offering precise and targeted removal of harmful blood components.

  • United States: The U.S. market is a leader in therapeutic apheresis, characterized by significant investment in advanced systems and disposable kits. There's a strong focus on integration with cell and gene therapies, as well as developing portable devices for decentralized care, aiming to enhance patient access and improve treatment outcomes for complex diseases.
  • China: China's therapeutic apheresis market is experiencing rapid growth, fueled by rising healthcare expenditure and an increasing burden of chronic diseases. The country is investing in modernizing its healthcare infrastructure and increasing the adoption of advanced apheresis techniques for a wide range of applications, especially in hematology.
  • Germany: Germany's market emphasizes high-quality apheresis equipment and innovative therapeutic applications, driven by a robust healthcare system and stringent quality standards. There's a notable focus on immunoadsorption and specific apheresis techniques for autoimmune and neurological disorders, reflecting a strong research and development ecosystem.
  • India: India's therapeutic apheresis market is expanding swiftly, propelled by the growing incidence of chronic and autoimmune diseases and improving healthcare infrastructure. Increased awareness among medical professionals and the adoption of modern apheresis procedures are contributing to market growth, with a focus on affordability and accessibility.
  • Japan: Japan's therapeutic apheresis market is characterized by technological sophistication and a high adoption rate of advanced apheresis systems. Driven by its aging population and demand for specialized treatments, there's a continuous push for innovations in selective apheresis and integration with regenerative medicine, notably in areas like LDL apheresis.

Features of the Global Therapeutic Apheresis Market

  • Market Size Estimates: Therapeutic apheresis market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Therapeutic apheresis market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Therapeutic apheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the therapeutic apheresis market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the therapeutic apheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the therapeutic apheresis market by type (therapeutic plasma exchange and red blood cell exchange), application (hospital, clinic, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Therapeutic Apheresis Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Therapeutic Plasma Exchange: Trends and Forecast (2019-2031)
  • 4.4 Red Blood Cell Exchange: Trends and Forecast (2019-2031)

5. Global Therapeutic Apheresis Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospital: Trends and Forecast (2019-2031)
  • 5.4 Clinic: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Therapeutic Apheresis Market by Region

7. North American Therapeutic Apheresis Market

  • 7.1 Overview
  • 7.2 North American Therapeutic Apheresis Market by Type
  • 7.3 North American Therapeutic Apheresis Market by Application
  • 7.4 United States Therapeutic Apheresis Market
  • 7.5 Mexican Therapeutic Apheresis Market
  • 7.6 Canadian Therapeutic Apheresis Market

8. European Therapeutic Apheresis Market

  • 8.1 Overview
  • 8.2 European Therapeutic Apheresis Market by Type
  • 8.3 European Therapeutic Apheresis Market by Application
  • 8.4 German Therapeutic Apheresis Market
  • 8.5 French Therapeutic Apheresis Market
  • 8.6 Spanish Therapeutic Apheresis Market
  • 8.7 Italian Therapeutic Apheresis Market
  • 8.8 United Kingdom Therapeutic Apheresis Market

9. APAC Therapeutic Apheresis Market

  • 9.1 Overview
  • 9.2 APAC Therapeutic Apheresis Market by Type
  • 9.3 APAC Therapeutic Apheresis Market by Application
  • 9.4 Japanese Therapeutic Apheresis Market
  • 9.5 Indian Therapeutic Apheresis Market
  • 9.6 Chinese Therapeutic Apheresis Market
  • 9.7 South Korean Therapeutic Apheresis Market
  • 9.8 Indonesian Therapeutic Apheresis Market

10. ROW Therapeutic Apheresis Market

  • 10.1 Overview
  • 10.2 ROW Therapeutic Apheresis Market by Type
  • 10.3 ROW Therapeutic Apheresis Market by Application
  • 10.4 Middle Eastern Therapeutic Apheresis Market
  • 10.5 South American Therapeutic Apheresis Market
  • 10.6 African Therapeutic Apheresis Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Therapeutic Apheresis Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 Miltenyi Biotec
    • Company Overview
    • Therapeutic Apheresis Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 Fresenius
    • Company Overview
    • Therapeutic Apheresis Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 Terumo
    • Company Overview
    • Therapeutic Apheresis Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 Baxter
    • Company Overview
    • Therapeutic Apheresis Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 Medica Group
    • Company Overview
    • Therapeutic Apheresis Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Therapeutic Apheresis Market
  • Figure 2.1: Usage of Therapeutic Apheresis Market
  • Figure 2.2: Classification of the Global Therapeutic Apheresis Market
  • Figure 2.3: Supply Chain of the Global Therapeutic Apheresis Market
  • Figure 3.1: Driver and Challenges of the Therapeutic Apheresis Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Therapeutic Apheresis Market ($B) by Type
  • Figure 4.3: Forecast for the Global Therapeutic Apheresis Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Therapeutic Plasma Exchange in the Global Therapeutic Apheresis Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Red Blood Cell Exchange in the Global Therapeutic Apheresis Market (2019-2031)
  • Figure 5.1: Global Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Therapeutic Apheresis Market ($B) by Application
  • Figure 5.3: Forecast for the Global Therapeutic Apheresis Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospital in the Global Therapeutic Apheresis Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Clinic in the Global Therapeutic Apheresis Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global Therapeutic Apheresis Market (2019-2031)
  • Figure 6.1: Trends of the Global Therapeutic Apheresis Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Therapeutic Apheresis Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Therapeutic Apheresis Market ($B) by Type (2019-2024)
  • Figure 7.3: Forecast for the North American Therapeutic Apheresis Market ($B) by Type (2025-2031)
  • Figure 7.4: North American Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Therapeutic Apheresis Market ($B) by Application (2019-2024)
  • Figure 7.6: Forecast for the North American Therapeutic Apheresis Market ($B) by Application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 8.1: European Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Therapeutic Apheresis Market ($B) by Type (2019-2024)
  • Figure 8.3: Forecast for the European Therapeutic Apheresis Market ($B) by Type (2025-2031)
  • Figure 8.4: European Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Therapeutic Apheresis Market ($B) by Application (2019-2024)
  • Figure 8.6: Forecast for the European Therapeutic Apheresis Market ($B) by Application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 9.1: APAC Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Therapeutic Apheresis Market ($B) by Type (2019-2024)
  • Figure 9.3: Forecast for the APAC Therapeutic Apheresis Market ($B) by Type (2025-2031)
  • Figure 9.4: APAC Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Therapeutic Apheresis Market ($B) by Application (2019-2024)
  • Figure 9.6: Forecast for the APAC Therapeutic Apheresis Market ($B) by Application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 10.1: ROW Therapeutic Apheresis Market by Type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Therapeutic Apheresis Market ($B) by Type (2019-2024)
  • Figure 10.3: Forecast for the ROW Therapeutic Apheresis Market ($B) by Type (2025-2031)
  • Figure 10.4: ROW Therapeutic Apheresis Market by Application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Therapeutic Apheresis Market ($B) by Application (2019-2024)
  • Figure 10.6: Forecast for the ROW Therapeutic Apheresis Market ($B) by Application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Therapeutic Apheresis Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Therapeutic Apheresis Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Therapeutic Apheresis Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Therapeutic Apheresis Market by Type
  • Figure 12.2: Growth Opportunities for the Global Therapeutic Apheresis Market by Application
  • Figure 12.3: Growth Opportunities for the Global Therapeutic Apheresis Market by Region
  • Figure 12.4: Emerging Trends in the Global Therapeutic Apheresis Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Therapeutic Apheresis Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Therapeutic Apheresis Market by Region
  • Table 1.3: Global Therapeutic Apheresis Market Parameters and Attributes
  • Table 3.1: Trends of the Global Therapeutic Apheresis Market (2019-2024)
  • Table 3.2: Forecast for the Global Therapeutic Apheresis Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Therapeutic Apheresis Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Therapeutic Apheresis Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Therapeutic Apheresis Market (2025-2031)
  • Table 4.4: Trends of Therapeutic Plasma Exchange in the Global Therapeutic Apheresis Market (2019-2024)
  • Table 4.5: Forecast for Therapeutic Plasma Exchange in the Global Therapeutic Apheresis Market (2025-2031)
  • Table 4.6: Trends of Red Blood Cell Exchange in the Global Therapeutic Apheresis Market (2019-2024)
  • Table 4.7: Forecast for Red Blood Cell Exchange in the Global Therapeutic Apheresis Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Therapeutic Apheresis Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Therapeutic Apheresis Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Therapeutic Apheresis Market (2025-2031)
  • Table 5.4: Trends of Hospital in the Global Therapeutic Apheresis Market (2019-2024)
  • Table 5.5: Forecast for Hospital in the Global Therapeutic Apheresis Market (2025-2031)
  • Table 5.6: Trends of Clinic in the Global Therapeutic Apheresis Market (2019-2024)
  • Table 5.7: Forecast for Clinic in the Global Therapeutic Apheresis Market (2025-2031)
  • Table 5.8: Trends of Others in the Global Therapeutic Apheresis Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global Therapeutic Apheresis Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Therapeutic Apheresis Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Therapeutic Apheresis Market (2025-2031)
  • Table 7.1: Trends of the North American Therapeutic Apheresis Market (2019-2024)
  • Table 7.2: Forecast for the North American Therapeutic Apheresis Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Therapeutic Apheresis Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Therapeutic Apheresis Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Therapeutic Apheresis Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Therapeutic Apheresis Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Therapeutic Apheresis Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Therapeutic Apheresis Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Therapeutic Apheresis Market (2019-2031)
  • Table 8.1: Trends of the European Therapeutic Apheresis Market (2019-2024)
  • Table 8.2: Forecast for the European Therapeutic Apheresis Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Therapeutic Apheresis Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Therapeutic Apheresis Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Therapeutic Apheresis Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Therapeutic Apheresis Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Therapeutic Apheresis Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Therapeutic Apheresis Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Therapeutic Apheresis Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Therapeutic Apheresis Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Therapeutic Apheresis Market (2019-2031)
  • Table 9.1: Trends of the APAC Therapeutic Apheresis Market (2019-2024)
  • Table 9.2: Forecast for the APAC Therapeutic Apheresis Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Therapeutic Apheresis Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Therapeutic Apheresis Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Therapeutic Apheresis Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Therapeutic Apheresis Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Therapeutic Apheresis Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Therapeutic Apheresis Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Therapeutic Apheresis Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Therapeutic Apheresis Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Therapeutic Apheresis Market (2019-2031)
  • Table 10.1: Trends of the ROW Therapeutic Apheresis Market (2019-2024)
  • Table 10.2: Forecast for the ROW Therapeutic Apheresis Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Therapeutic Apheresis Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Therapeutic Apheresis Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Therapeutic Apheresis Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Therapeutic Apheresis Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Therapeutic Apheresis Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Therapeutic Apheresis Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Therapeutic Apheresis Market (2019-2031)
  • Table 11.1: Product Mapping of Therapeutic Apheresis Suppliers Based on Segments
  • Table 11.2: Operational Integration of Therapeutic Apheresis Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Therapeutic Apheresis Revenue
  • Table 12.1: New Product Launches by Major Therapeutic Apheresis Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Therapeutic Apheresis Market